Aurora Cannabis Inc. (ACB)
| Previous close | 5.89 |
| Open | 5.96 |
| Bid | 5.88 x 400 |
| Ask | 6.01 x 1100 |
| Day's range | 5.90 - 5.98 |
| 52-week range | 2.84 - 11.50 |
| Volume | |
| Avg. volume | 7,935,184 |
| Market cap | 325.125M |
| Beta (5Y monthly) | 2.65 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -58.15 |
| Earnings date | 12 Jun 2024 - 17 Jun 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 32.19 |
PR NewswireAurora Unveils Premium Resin Cartridges in Australia
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) – the Canadian based leading global medical cannabis company, in conjunction with MedReleaf Australia, is excited to announce the launch of its premium 1.2g resin cartridges in Australia. This expansion marks a significant step in Aurora's mission to provide high-quality products to patients worldwide. Now available for doctors to prescribe to patients in Australia, Aurora's new resign cartridges, developed and manufactured at the company's EU-GMP an
ZacksSol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Lags Revenue Estimates
SolGel Technologies (SLGL) delivered earnings and revenue surprises of -53.33% and 64.15%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ZacksStrength Seen in Canopy Growth (CGC): Can Its 11.0% Jump Turn into More Strength?
Canopy Growth (CGC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
